Alignment Healthcare, Inc. (NASDAQ:ALHC) President Sells $411,600.00 in Stock

Alignment Healthcare, Inc. (NASDAQ:ALHCGet Free Report) President Dawn Christine Maroney sold 30,000 shares of the firm’s stock in a transaction on Tuesday, February 18th. The stock was sold at an average price of $13.72, for a total value of $411,600.00. Following the completion of the sale, the president now directly owns 1,576,097 shares of the company’s stock, valued at $21,624,050.84. This represents a 1.87 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Dawn Christine Maroney also recently made the following trade(s):

  • On Wednesday, January 15th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The stock was sold at an average price of $13.61, for a total value of $408,300.00.

Alignment Healthcare Stock Performance

Alignment Healthcare stock opened at $13.17 on Friday. Alignment Healthcare, Inc. has a 1-year low of $4.46 and a 1-year high of $15.82. The company has a current ratio of 1.60, a quick ratio of 1.60 and a debt-to-equity ratio of 1.82. The firm has a market capitalization of $2.52 billion, a PE ratio of -17.10 and a beta of 1.50. The firm’s 50 day simple moving average is $13.19 and its 200 day simple moving average is $11.78.

Wall Street Analysts Forecast Growth

ALHC has been the topic of a number of research reports. Barclays boosted their price objective on Alignment Healthcare from $7.00 to $8.00 and gave the company an “underweight” rating in a research note on Wednesday, October 30th. UBS Group boosted their price target on shares of Alignment Healthcare from $9.00 to $12.00 and gave the company a “neutral” rating in a research report on Wednesday, October 30th. Stifel Nicolaus raised their price objective on shares of Alignment Healthcare from $14.00 to $16.00 and gave the stock a “buy” rating in a report on Tuesday, January 14th. Finally, Stephens reissued an “overweight” rating and set a $17.00 target price on shares of Alignment Healthcare in a report on Thursday, January 2nd. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating, seven have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, Alignment Healthcare currently has an average rating of “Moderate Buy” and a consensus target price of $11.88.

Read Our Latest Research Report on Alignment Healthcare

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in ALHC. Vanguard Group Inc. boosted its stake in Alignment Healthcare by 1.7% during the fourth quarter. Vanguard Group Inc. now owns 9,818,071 shares of the company’s stock valued at $110,453,000 after buying an additional 166,837 shares during the period. T. Rowe Price Investment Management Inc. raised its holdings in shares of Alignment Healthcare by 54.7% in the 4th quarter. T. Rowe Price Investment Management Inc. now owns 8,649,042 shares of the company’s stock valued at $97,302,000 after acquiring an additional 3,059,596 shares in the last quarter. Wellington Management Group LLP boosted its position in shares of Alignment Healthcare by 77.9% during the 4th quarter. Wellington Management Group LLP now owns 7,438,500 shares of the company’s stock valued at $83,683,000 after acquiring an additional 3,257,630 shares during the last quarter. Hood River Capital Management LLC grew its holdings in shares of Alignment Healthcare by 39.6% during the fourth quarter. Hood River Capital Management LLC now owns 4,952,995 shares of the company’s stock worth $55,721,000 after purchasing an additional 1,405,212 shares in the last quarter. Finally, 8 Knots Management LLC increased its position in shares of Alignment Healthcare by 49.5% in the fourth quarter. 8 Knots Management LLC now owns 3,658,695 shares of the company’s stock worth $41,160,000 after purchasing an additional 1,211,727 shares during the last quarter. Institutional investors own 86.19% of the company’s stock.

About Alignment Healthcare

(Get Free Report)

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.

Featured Stories

Insider Buying and Selling by Quarter for Alignment Healthcare (NASDAQ:ALHC)

Receive News & Ratings for Alignment Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alignment Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.